欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/4117/003
药品名称
Atazanavir Sandoz 200 mg, harde capsules
活性成分
ATAZANAVIR sulfate 228.0 mg
剂型
Capsule, hard
上市许可持有人
Sandoz B.V. Almere Netherlands
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
France (FR)
Latvia (LV)
Atazanavir Sandoz 200 mg cietās kapsulas
许可日期
2018/09/19
最近更新日期
2024/07/05
药物ATC编码
J05AE08 atazanavir
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
common_pl
Date of last change:2023/06/28
Final SPC
|
common_spc
Date of last change:2023/06/28
Final Labelling
|
1.3.1 spc-label-pl - common-outer - 5,857
Date of last change:2021/06/04
Final Product Information
|
common-outer - clean
Date of last change:2020/01/02
Final Product Information
|
common-pl - clean
Date of last change:2020/01/02
PAR Summary
|
190723 NL.H.4117.001-004.DC Atazanavir Sandoz summary EN
Date of last change:2019/07/30
PAR
|
190723 NL.H.4117.001-004.DC Atazanavir Sandoz PAR
Date of last change:2019/07/30
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase